NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.240
-0.150 (-10.79%)
Mar 9, 2026, 4:00 PM EDT - Market closed
NovaBay Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 32 | 3 | 1 | 4 | 17 | 29 | |
| Market Cap Growth | 944.99% | 120.45% | -66.44% | -76.55% | -41.88% | 63.08% | |
| Enterprise Value | 29 | 3 | 3 | 3 | 8 | 16 | |
| Last Close Price | 1.39 | 1.99 | 23.60 | 225.57 | 1524.75 | 2821.97 | |
| PS Ratio | 2.90 | 0.30 | 0.13 | 0.28 | 1.66 | 2.93 | |
| PB Ratio | 18.31 | -22.76 | 0.40 | 0.38 | 1.66 | 2.36 | |
| P/TBV Ratio | - | - | 0.98 | 0.80 | - | 2.36 | |
| EV/Sales Ratio | 2.77 | 0.35 | 0.27 | 0.20 | 0.79 | 1.65 | |
| Debt / Equity Ratio | 0.59 | -12.96 | 0.79 | 0.19 | 0.05 | 0.04 | |
| Net Debt / Equity Ratio | -0.82 | -9.63 | -0.09 | -0.31 | -0.68 | -0.93 | |
| Net Debt / EBITDA Ratio | 0.26 | -0.25 | 0.08 | 0.46 | 0.80 | 1.80 | |
| Net Debt / FCF Ratio | -0.45 | -0.23 | 0.07 | 0.49 | 0.75 | 2.41 | |
| Asset Turnover | 2.80 | 1.57 | 0.82 | 0.71 | 0.52 | 0.75 | |
| Inventory Turnover | - | 5.21 | 2.11 | 1.83 | 1.76 | 7.22 | |
| Quick Ratio | 1.89 | 0.29 | 0.84 | 1.72 | 2.67 | 4.61 | |
| Current Ratio | 2.00 | 0.68 | 1.67 | 2.66 | 3.83 | 5.03 | |
| Return on Equity (ROE) | -516.26% | -452.75% | -88.62% | -102.37% | -51.79% | -166.11% | |
| Return on Assets (ROA) | -86.98% | -49.91% | -20.16% | -23.78% | -28.25% | -30.36% | |
| Return on Capital Employed (ROCE) | -251.30% | -857.60% | -86.20% | -63.30% | -43.20% | -51.80% | |
| Earnings Yield | 10.84% | -245.99% | -723.74% | -267.27% | -34.41% | -37.91% | |
| FCF Yield | 9.87% | -183.74% | -349.33% | -170.47% | -54.62% | -16.30% | |
| Buyback Yield / Dilution | -831.36% | -2730.00% | - | - | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.